Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Krolicki
- Address
- Aleja Piastow 65/U5, 70-332 Szczecin, Poland
Immune System Diseases
The Laser Clinic in Szczecin is advancing research in immune system diseases, with a focus on chronic urticaria. One study aims to confirm therapeutic equivalence of a new agent compared with an established therapy for patients who have not responded adequately to standard antihistamines.
- Therapeutic equivalence assessment
- Biologic treatment comparison
- Patient‑reported outcome evaluation
These investigations highlight the clinic’s commitment to improving care options for individuals living with chronic urticaria.
Skin and Connective Tissue Diseases
Research at the Laser Clinic also targets skin and connective tissue diseases, specifically hidradenitis suppurativa. A current trial evaluates the efficacy, safety, and tolerability of a novel biologic agent aimed at reducing lesions and enhancing quality of life for affected adults.
- Efficacy and safety evaluation
- Lesion reduction analysis
- Quality of life improvement
This work underscores the site’s role in developing innovative treatments for challenging dermatologic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Krolicki
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparison of Efficacy and Safety of BP11 and EU-Approved Omalizumab in Chronic Spontaneous Urticaria Resistant to H1 Antihistamines | Curateq Biologics Private Limited | Phase III | Not Recruiting | Sep 2023 | Mar 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Omalizumab | 1 | Unknown | 2023-09-27 | 2023-09-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.